A MULTICENTER, OPEN-LABEL, EXTENSION STUDY INTENDED TO EVALUATE THE LONG-TERM SAFETY OF ECOPIPAM TABLETS IN CHILDREN AND ADOLESCENT SUBJECTS WITH TOURETTE¿S SYNDROME.

Registry ID

EBS-101-OL-001

Source registry

HEALTH_CANADA

Status

Closed

Study type

INTERVENTIONAL

Sponsor

EMALEX BIOSCIENCES, INC

Start date

2022-04-13

Completion date

2022-11-11

Last update

2019-05-31

Conditions

• TOURETTE¿S SYNDROME

Related clinical trials

• AN OPEN-LABEL, LONG-TERM SAFETY STUDY INCLUDING A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL PERIOD OF TEV-50717 (DEUTETRABENAZINE) FOR THE TREATMENT OF TOURETTE SYNDROME IN CHILDREN AND ADOLESCENTS
• A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CROSSOVER PILOT TRIAL OF MEDICAL CANNABIS IN ADULTS WITH TOURETTE SYNDROME.

View on source registry